Deep vein thrombosis risk stratification: Pulmonary thromboembolism and antithrombotic therapy

International Heart Journal

Volumn 54, Issue 3, 2013, Pages 166-170

  Nitta, Daisuke ^a   Mitani, Haruo ^a   Ishimura, Rieko ^a   Moriya, Manabu ^a   Fujimoto, Yo ^a   Ishiwata, Sugao ^a   Yamaguchi, Tetsu ^a   Ohno, Minoru ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Anticoagulation therapy; Below knee vein thrombosis; Pulmonary thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; DEEP VEIN THROMBOSIS; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

AGED; ANTICOAGULANTS; FEMALE; HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOSIS;

EID: 84879036873     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.54.166     Document Type: Article

References (13)

1. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-1389.
2. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl): 381S-453S.
3. Japanese Circulation Society. Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2004). J Cardiol 2005; 45: 349-366. (Japanese)
4. Rosfors S, Persson LM, Lärfars G, Lapidus LJ. A follow-up study of the fate of small asymptomatic deep venous thromboses. Thromb J 2010; 8: 4.
5. Spencer FA, Emery C, Lessard D, et al. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med 2006; 21: 722-727.
6. Pisters R, Lane DA, Nieuwlaat R, de Vo s CB, Crijns HJ, Lip G Y. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fbrillation: the Euro Heart Survey. Chest 2010; 138: 1093-1100.
7. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous throm-boembolism. JAMA 1998; 279: 458-462.
8. Schulman S, Beyth RJ, Kearon C, Levine MN. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 257S-298S.
9. Fanikos J, Grasso-Correnti N, Shah R, Kucher N, Goldhaber SZ. Major bleeding complications in a specialized anticoagulation service. Am J Cardiol 2005; 96: 595-598.
10. Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med 2007; 167: 1414-1419.
11. Cogo A, Lensing AW, Prandoni P, Hirsh J. Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound. Arch Intern Med 1993; 153: 2777-2780.
12. Macdonald PS, Kahn SR, Miller N, Obrand D. Short-term natural history of isolated gastrocnemius and soleal vein thrombosis. J Vasc Surg 2003; 37: 523-527.
13. Toyoda K, Yasaka M, Iwade K, et al. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study. Stroke 2008; 39: 1740-1745.